Patients who come to my clinic after a cirrhosis diagnosis frequently arrive with a distorted picture of the waiting list — either expecting a quick resolution or, equally, a hopeless multi-year queue. The reality is more nuanced, more manageable, and more dependent on active participation than most people realise. Understanding the system is not optional; it is part of the clinical preparation for transplant.

This post covers the full picture: national and regional allocation structures, the role of your MELD score, the dominant role of living donor transplant in India, and the practical steps you must take while listed. Discuss all clinical information with your treating physician before acting on it — your specific situation may differ from the general framework described here.

How is the liver transplant waiting list in India structured?

India’s organ allocation system is not a single national queue. It operates as a three-tier hierarchy: NOTTO at the apex, five Regional Organ and Tissue Transplant Organisations (ROTTOs) at the intermediate level, and State Organ and Tissue Transplant Organisations (SOTTOs) or equivalent bodies managing local waiting lists and allocation. Maharashtra is a special case: it operates four Zonal Transplant Co-ordination Centres (ZTCCs) covering Mumbai, Pune, Nagpur, and Aurangabad rather than a single SOTTO.

Patients cannot register themselves directly with NOTTO or a ZTCC. Registration happens through a NOTTO-accredited transplant centre — the transplant team submits the documentation on the patient’s behalf after a full evaluation. Once registered, patients must wait a minimum of five days before becoming eligible to receive an organ offer from the cadaveric list, except in the super-urgent category where this waiting period is waived. Blood group-wise waiting lists are maintained separately within each zone, which has a direct bearing on how long different patients wait. When no compatible recipient exists within a state’s list, the organ moves up to the regional and then national pool — organs are not wasted if local recipients cannot be identified within the allocation window.

What is NOTTO and how does it allocate cadaveric organs?

NOTTO (National Organ and Tissue Transplant Organisation), under the Ministry of Health and Family Welfare, sets national policy, maintains the central organ transplant registry, and manages allocation directly for the Delhi/NCR region. Outside Delhi, each ROTTO and its constituent SOTTOs or ZTCCs apply allocation rules that follow the national framework but retain local variations.

The allocation sequence follows urgency first, then waiting time and blood group compatibility. At the top of every list sits the super-urgent category — patients with acute liver failure, primary graft non-function after a prior transplant, or hepatic artery thrombosis in the early post-transplant period. Below that, standard listed patients are prioritised by the rules applicable to their ZTCC or SOTTO, with blood group identity as the first filter. An organ from a group A donor goes to group A recipients; group AB donors can help AB recipients. The practical consequence for blood group O patients is that O-group organs are restricted to O-group recipients, while O-group patients cannot receive from non-O donors under standard allocation — a structural disadvantage that tends to lengthen their wait relative to other groups.

How does your MELD score affect your position on the waiting list?

The MELD score — Model for End-stage Liver Disease — is calculated from three laboratory values: serum bilirubin, serum creatinine, and the INR. It quantifies the probability of death within 90 days in a patient with end-stage liver disease, with scores typically ranging from around 6 to 40. A score of 12 in a compensated cirrhotic patient is a very different clinical reality from a score of 28 in someone with refractory ascites and a recent episode of hepatic encephalopathy. The number summarises a complex clinical picture into a single figure that guides both listing decisions and, in some allocation frameworks, queue priority.

Most programmes begin listing for deceased-donor transplant at a MELD score of around 15. The evidence for that threshold comes from a US registry study of nearly 13,000 waiting-list patients: transplant increased one-year mortality at MELD below 15 and reduced it from MELD 18 upward (Merion et al., Am J Transplant 2005). Patients with hepatocellular carcinoma within accepted criteria — typically the Milan or UCSF criteria — may be listed at any MELD, because the listing indication is oncological urgency rather than biochemical liver reserve alone.

A rising MELD is a signal your transplant team needs promptly. An increase of four or more points over four weeks is clinically significant. If your score crosses 25, the urgency of both the cadaveric listing and living donor evaluation intensifies — survival on the waiting list without transplant at very high MELD scores drops substantially. Your team should know about any new hospitalisation, infection, or deterioration as soon as it happens, not at the next scheduled appointment.

How long is the wait for a cadaveric liver in India — what factors affect timing?

No reliable national average exists for cadaveric liver wait time in India, because the actual duration is determined by factors that vary enormously between patients: blood group, ZTCC zone, the current rate of deceased donation in that zone, and how many super-urgent cases are in the queue competing for the same organs. India’s deceased-donor rate remains very low by international standards — historically around 0.5 per million population, compared to over 20 per million in countries such as Spain. That disparity produces a cadaveric supply that is simply insufficient to serve the number of patients who could benefit from transplant.

Blood group O patients face structurally longer waits for the reason described above. Patients in zones with lower deceased-donor hospital activity may wait longer than those listed at centres in high-volume cities. And the super-urgent allocation tier means that a period of increased donation activity in a region does not necessarily translate to shorter waits for standard-listed patients if multiple acute liver failure cases arise during the same period.

For patients with chronic liver cirrhosis and a MELD in the 15–22 range, the practical guidance is clear: being listed is the right clinical step, but planning a living donor evaluation in parallel is equally important. The cadaveric list is a real option; it is not a fast one for most patients in India.

Is living donor liver transplant a faster route — and who can donate?

Living donor liver transplant (LDLT) bypasses the cadaveric waiting list entirely. The surgery is planned electively, with timing driven by both parties’ readiness rather than the unpredictable availability of a deceased donor. In the Indian context, this matters more than anywhere else: LDLT accounts for the large majority of liver transplants performed in India (Narasimhan, Hepatobiliary Surg Nutr 2016), reflecting the scarcity of deceased donors rather than any clinical inferiority of cadaveric grafts. India has become a global leader in living-donor liver transplant volume and outcomes, with results at experienced centres comparable to international benchmarks — a framework I describe in more detail on the liver transplant India overview page.

Who can donate? The evaluation is rigorous. Donors must generally be between 18 and 55 years of age, in good general health, ABO blood-group compatible with the recipient, and within a healthy weight range. Indian law requires donors to be near relatives of the recipient — parents, children, siblings, or spouse — or to receive authorisation from an appropriate committee for non-related donation. The donor undergoes a full assessment: liver volumetry on CT to calculate graft-to-recipient weight ratio, cardiac and pulmonary clearance, psychological evaluation, and blood tests. For adult-to-adult transplant, the right lobe of the donor liver is typically used. The donor’s remnant liver regenerates to near-normal volume within six to eight weeks in most healthy individuals.

Potential donors will find the evaluation process, surgical risks, recovery timeline and long-term outcomes covered in my guide for living liver donors. For NRI patients and international families co-ordinating their workup before travelling to Mumbai, the international patient guide covers the full logistics of dual-evaluation at Gleneagles.

What must you do to stay active and ready while on the waiting list?

Being listed is not a passive state. A patient who is registered but disengaged from follow-up is at risk of two separate failures: missing a clinical deterioration that a prompt intervention could have managed, and — in the worst scenario — being unreachable when an organ becomes available. Both are avoidable.

Follow-up frequency should match MELD. At scores of 15–18, every six to eight weeks is typical. As MELD climbs toward and above 25, monthly or more frequent reviews become necessary to keep the score current and to reassess surgical fitness. At each visit, your team should update blood tests, recalculate MELD, and screen for complications of cirrhosis — infection, renal function, nutritional status, and muscle mass. Sarcopenia (severe muscle wasting) affects transplant outcomes; addressing it before surgery through dietary optimisation and, where possible, supervised activity is part of the preparation, not an afterthought.

Contactability is non-negotiable. When an organ becomes available, the transplant centre will call. If you cannot be reached within the allocated response window, the organ will be offered to the next eligible patient on the list. Register working numbers for at least one family member alongside your own, and inform the centre immediately of any address change or planned travel. Do not begin any new herbal preparation, traditional remedy, or over-the-counter supplement without informing your hepatologist — several cause direct hepatotoxicity and can drive a previously stable MELD into a range that changes both urgency and operability. And if fever, increasing abdominal distension, or confusion develops, present to your transplant centre rather than managing it locally. A single unrecognised episode of spontaneous bacterial peritonitis or acute kidney injury can shift the clinical picture dramatically. Always discuss changes in your condition with your physician before acting on any information you read.